<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>BIOTEST 1 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sat, 04 Apr 2026 04:37:22 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/biotest%5F1%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>BIOTEST 1 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>EQS-News: Biotest gibt US-FDA-Zulassung für Grifols Fesilty™ (Fibrinogen, human-chmt) bekannt</title><pubDate>Fri, 19 Dec 2025 12:00:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-gibt-us-fda-zulassung-f-r-grifols-fesilty-fibrinogen-human-chmt-bekannt-15370736</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS-News: Biotest AG


 / Schlagwort(e): Zulassungsgenehmigung


<br/>


Biotest gibt US-FDA-Zulassung für Grifols Fesilty™ (Fibrinogen, human-chmt) bekannt <br/><br/>






19.12.2025 / 12:00 CET/CEST<br/>



Für  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-gibt-us-fda-zulassung-f-r-grifols-fesilty-fibrinogen-human-chmt-bekannt-15370736</guid></item><item><title>EQS-News: Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt)</title><pubDate>Fri, 19 Dec 2025 12:00:03 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-announces-us-fda-approval-of-grifols-fesilty-fibrinogen-human-chmt-15370738</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: Biotest AG


 / Key word(s): Regulatory Approval


<br/>


Biotest announces US FDA approval of Grifols’ Fesilty™ (fibrinogen, human-chmt) <br/><br/>






19.12.2025 / 12:00 CET/CEST<br/>



The issuer  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-announces-us-fda-approval-of-grifols-fesilty-fibrinogen-human-chmt-15370738</guid></item><item><title>EQS-News: Biotest erhält Zulassung für neues Human Fibrinogen Prufibry® in Deutschland  </title><pubDate>Thu, 13 Nov 2025 10:07:42 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-erh-lt-zulassung-f-r-neues-human-fibrinogen-prufibry-in-deutschland-15271154</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS-News: Biotest AG


 / Schlagwort(e): Zulassungsgenehmigung


<br/>


Biotest erhält Zulassung für neues Human Fibrinogen Prufibry® in Deutschland   <br/><br/>






13.11.2025 / 10:07 CET/CEST<br/>



Für den  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-erh-lt-zulassung-f-r-neues-human-fibrinogen-prufibry-in-deutschland-15271154</guid></item><item><title>EQS-News: Biotest obtains approval for new human fibrinogen Prufibry® in Germany </title><pubDate>Thu, 13 Nov 2025 10:07:42 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-obtains-approval-for-new-human-fibrinogen-prufibry-in-germany-15271155</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: Biotest AG


 / Key word(s): Regulatory Approval


<br/>


Biotest obtains approval for new human fibrinogen Prufibry® in Germany  <br/><br/>






13.11.2025 / 10:07 CET/CEST<br/>



The issuer is solely  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-obtains-approval-for-new-human-fibrinogen-prufibry-in-germany-15271155</guid></item><item><title>EQS-News: Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A.</title><pubDate>Fri, 07 Nov 2025 15:19:33 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-extraordinary-general-meeting-convened-again-at-the-request-of-grifols-s-a-15220647</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: Biotest AG


 / Key word(s): AGM/EGM


<br/>


Biotest AG: Extraordinary general meeting convened again at the request of Grifols S.A. <br/><br/>






07.11.2025 / 15:19 CET/CEST<br/>



The issuer is  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-extraordinary-general-meeting-convened-again-at-the-request-of-grifols-s-a-15220647</guid></item><item><title>EQS-News: Biotest AG: Erneute Einberufung einer außerordentlichen Hauptversammlung auf Verlangen  der Grifols S.A.</title><pubDate>Fri, 07 Nov 2025 15:19:33 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-erneute-einberufung-einer-au-erordentlichen-hauptversammlung-auf-verlangen-der-grifols-s-a-15220648</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS-News: Biotest AG


 / Schlagwort(e): Hauptversammlung


<br/>


Biotest AG: Erneute Einberufung einer außerordentlichen Hauptversammlung auf Verlangen  der Grifols S.A. <br/><br/>






07.11.2025 / 15:19 CET/CEST<br/>



Für  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-erneute-einberufung-einer-au-erordentlichen-hauptversammlung-auf-verlangen-der-grifols-s-a-15220648</guid></item><item><title>EQS-News: Biotest AG: Absage der außerordentlichen Hauptversammlung am 28. Oktober 2025</title><pubDate>Thu, 23 Oct 2025 13:16:43 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-absage-der-au-erordentlichen-hauptversammlung-am-28-oktober-2025-15110692</link><description><![CDATA[<p>


	







<table border="0"><tr><td>


EQS-News: Biotest AG


 / Schlagwort(e): Hauptversammlung


<br/>


Biotest AG: Absage der außerordentlichen Hauptversammlung am 28. Oktober 2025 <br/><br/>






23.10.2025 / 13:16 CET/CEST<br/>



Für den Inhalt  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-absage-der-au-erordentlichen-hauptversammlung-am-28-oktober-2025-15110692</guid></item><item><title>EQS-News: Biotest AG: Cancellation of the extraordinary general meeting on 28 October 2025</title><pubDate>Thu, 23 Oct 2025 13:16:43 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-cancellation-of-the-extraordinary-general-meeting-on-28-october-2025-15110693</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: Biotest AG


 / Key word(s): AGM/EGM


<br/>


Biotest AG: Cancellation of the extraordinary general meeting on 28 October 2025 <br/><br/>






23.10.2025 / 13:16 CET/CEST<br/>



The issuer is solely  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-ag-cancellation-of-the-extraordinary-general-meeting-on-28-october-2025-15110693</guid></item><item><title>EQS-News: Biotest’s Yimmugo® launches in the United States</title><pubDate>Thu, 09 Oct 2025 17:30:13 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-s-yimmugo-launches-in-the-united-states-14984410</link><description><![CDATA[<p>



	






<table border="0"><tr><td>


EQS-News: Biotest AG


 / Key word(s): Product Launch


<br/>


Biotest’s Yimmugo® launches in the United States <br/><br/>






09.10.2025 / 17:30 CET/CEST<br/>



The issuer is solely responsible for the content  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biotest-s-yimmugo-launches-in-the-united-states-14984410</guid></item></channel></rss>
